Product image of Nolpaza Control (Pantoprazole) supplied by GNH India

Nolpaza Control

Active Ingredient:
Pantoprazole
Origin:
EU

Nolpaza Control (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza Control, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome.

GNH India supplies Nolpaza Control as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, and procurement teams across global markets, ensuring quality, regulatory compliance and timely delivery. Our supply chain adheres to EU GMP standards and supports local import requirements.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal conditions.

  • Gastro‑oesophageal reflux disease (GERD): reduces esophageal acid exposure and relieves heartburn and regurgitation.
  • Erosive esophagitis: promotes healing of acid‑induced esophageal lesions.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.
  • Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring long‑term NSAID therapy.
  • Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics.

How It Works

  • Pantoprazole selectively and irreversibly binds to the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces the volume and acidity of gastric juice, providing sustained control of gastric acidity.

Side Effects

Common Side Effects

  • Headache: mild, transient headache.
  • Diarrhea: loose stools, usually self‑limiting.
  • Nausea: occasional feeling of queasiness.
  • Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention.
  • Low magnesium levels: muscle cramps, weakness, or irregular heartbeat.
  • Clostridioides difficile infection: severe diarrhea and abdominal pain that may occur with prolonged use.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Assess renal function: dose adjustment may be needed in severe impairment.
  • Monitor for infection: prolonged use can increase risk of Clostridioides difficile infection.
  • Avoid concomitant use with drugs that require gastric acidity for absorption.
  • Use with caution in pregnancy: safety not established; weigh benefits against potential risks.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Pantoprazole may interact with several medicines; review the following:

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect, potentially decreasing cardiovascular protection.
  • Atazanavir: decreased absorption of atazanavir, leading to sub‑therapeutic levels.
  • Methotrexate: increased methotrexate toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR, requiring closer coagulation monitoring.
  • Digoxin: may raise serum digoxin concentrations, necessitating dose adjustment.
  • Iron supplements: reduced iron absorption; consider spacing administration times.

Frequently Asked Questions

Nolpaza Control, containing pantoprazole, is prescribed to treat acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, to prevent NSAID‑induced gastric ulcers, and as part of combination therapy for Helicobacter pylori eradication.

Pantoprazole inhibits the gastric H+/K+ ATPase (proton pump) in the parietal cells of the stomach. By blocking this final step of acid secretion, it reduces both the volume and acidity of gastric juice, providing prolonged control of stomach acidity.

The specific dose and dosing schedule of Nolpaza Control are determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for pantoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Nolpaza Control (pantoprazole) is a potent proton pump inhibitor with a favorable drug‑interaction profile compared with some other PPIs that may affect cytochrome P450 enzymes. It provides similar acid‑suppression efficacy to alternatives such as omeprazole or esomeprazole, but individual response and tolerability can vary, so clinicians choose based on patient factors and drug‑interaction considerations.

Store Nolpaza Control at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure they are out of reach of children.

Nolpaza Control is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistency in relation to meals helps maintain steady drug levels. Patients should swallow the tablet whole and not crush or chew it.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), low magnesium levels that can cause muscle cramps or cardiac arrhythmias, and Clostridioides difficile infection leading to severe diarrhea. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, difficulty breathing, persistent diarrhea, or muscle weakness.

Patients with known hypersensitivity to pantoprazole or any component of the formulation should avoid Nolpaza Control. Caution is advised in individuals with severe liver disease, those taking medications that require gastric acidity for absorption, and patients with a history of C. difficile infection. The prescriber will assess suitability on a case‑by‑case basis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT